|本期目录/Table of Contents|

[1]张 萌,田伟军.71例原发性甲状旁腺功能亢进诊治及PTH、Ca分析[J].天津医科大学学报,2015,21(04):338-341.
点击复制

71例原发性甲状旁腺功能亢进诊治及PTH、Ca分析(PDF)
分享到：

《天津医科大学学报》[ISSN:1006-8147/CN:12-1259/R]

卷:
21卷
期数:
2015年04期
页码:
338-341
栏目:
临床医学
出版日期:
2015-07-15

文章信息/Info

Title:
-
文章编号:
1006-8147（2015）04-0338-04
作者:
张 萌; 田伟军
(天津医科大学总医院普通外科, 天津 300052)
Author(s):
-
关键词:
原发性甲状旁腺功能亢进; 甲状旁腺肿瘤; 甲状旁腺激素; 血钙
Keywords:
-
分类号:
R653
DOI:
-
文献标志码:
A
摘要:
目的： 总结原发性甲状旁腺功能亢进的诊治体会，分析围手术期甲状旁腺激素（PTH）、血钙（Ca）变化 。方法： 回顾性分析原发性甲状旁腺功能亢进71例患者临床资料。 结果： 71例患者， PTH升高者占100.0%、Ca升高占94.4%、血磷降低占58.9%；病灶检出率B超为86.0%、CT增强为93.8%、99 Tcm－MIBI 为95.2%；术前、切皮前、肿物切除前、切除即刻、切除后10、15、30 min及术后1、2、3 d PTH为(86.51±78.29)、(99.84±104.33)、(113.06±86.73)、(41.39±37.70)、(11.10±10.22)、(10.43±9.29)、(5.87±8.23)、(3.25±6.14)、(3.70±3.48)、(7.74±3.71)pmol/L；术前、术后当天及1、2、3、4 d血钙为(2.88±0.34)、(2.56±0.37)、(2.27±0.27)、(2.17±0.26)、(2.09±0.21)、(2.00±0.25)mmol/L；术后低钙血症发生率为75.4%，骨型比例为84.6%。结论：原发性甲状旁腺功能亢进诊治需综合运用各影像学检查，术中肿物切除后10 min PTH的变化明显，适宜作为监测指标，术后2 d内低钙血症发生率高，需重视治疗。
Abstract:
-

参考文献/References:

[1]董建宇，管珩，朱预．甲状旁腺功能亢进症455例临床症状分析[J]．中国医学科学院学报，2011，33（3）：330
[2]Luigi P, Chiara F M, Laura Z A, et al. Arterial hypertension, metabolic syndrome and subclinical cardiovascular organ damage in patients with asymptomatic primary hyperparathyroidism before and after parathyroidectomy: preliminary results[J]. Int J Endocrinol, 2012，2012: 408295
[3]Bilezikian J P, Khan A A, Potts J T, et al. Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the third international workshop[J]. J Clin Endocrinol Metab, 2009, 94(2): 335
[4]Schneider D F, Mazeh H, Sippel R S, et al. Is minimally invasive parathyroidectomy associated with greater recurrence compared to bilateral exploration? Analysis of more than 1,000 cases[J]. Surgery, 2012, 152(6): 1008
[5]朱预，孟迅吾，管珩，等．甲状旁腺腺瘤单侧探查的经验[J]．中华外科杂志，1993，1（）：605
[6]Ryan S, Courtney D, Timon C. Co-existent thyroid disease in patients treated for primary hyperparathyroidism: implications for clinical management[J]. Eur Arch Otorhinolaryngol, 2014?[Epub ahead of print]
[7]Karakas E, Müller H H, Schlosshauer T, et al. Reoperations for primary hyperparathyroidism--improvement of outcome over two decades[J]. Langenbecks Arch Surg, 2013, 398(1): 99
[8]Wei C H, Harari A. Parathyroid carcinoma: update and guidelines for management[J]. Curr Treat Options Oncol, 2012, 13(1): 11
[9]Stack B C, Moore E R, Belcher R H, et al. Hormone, relationships of parathyroid gamma counts, and adenoma mass in minimally invasive parathyroidectomy[J]. Otolaryngol Head Neck Surg, 2012, 147(6): 1035
[10]Sokoll L J, Wians F H, Remaley A T. Rapid intraoperative immunoassay of parathyroid hormone and other hormones: a new paradigm for point-of-care testing[J]. Clin Chem, 2004, 50(7): 1126
[11]Lee S, Ryu H, Morris L F, et al. Operative failure in minimally invasive parathyroidectomy utilizing an intraoperative parathyroid hormone assay[J]. Ann Surg Oncol, 2014, 21(6): 1878
[12]Lombardi C P, Raffaelli M, Traini E, et al. Video-assisted minimally invasive parathyroidectomy: benefits and long-term results[J]. World J Surg, 2009, 33(11): 2266
[13]钟春林，樊友本．腔镜辅助甲状旁腺微创手术[J]．腹腔镜外科杂志，2011，16（8）：576
[14]Rajeev P, Stechman M J, Kirk H A, et al. Safety and efficacy of minimally-invasive parathyroidectomy (MIP) under local anaesthesia without intra-operative PTH measurement[J]. Int J Surg, 2013, 11(3): 275.
[15]Karakas E, Steinfeldt T, Gockel A, et al. Transoral parathyroid surgery—a new alternative or nonsense?[J]. Langenbecks Arch Surg, 2014, 399(6): 741
[16]Noureldine S I, Lewing N, Tufano R P, et al. The role of the robotic-assisted transaxillary gasless approach for the removal of parathyroid adenomas[J]. ORL J Otorhinolaryngol Relat Spec, 2014, 76(1): 19

相似文献/References:

备注/Memo

备注/Memo:
作者简介 张萌（1989-），男，硕士在读 ，研究方向：肝胆外科、内分泌外科；

通信作者：田伟军，E-mail：jonathontian@163.com。

更新日期/Last Update: 2015-07-17